- Home
- VRDN vs CET Comparison
VRDN vs CET Comparison
Compare VRDN & CET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- CET
- Stock Information
- Founded
- VRDN 2006
- CET 1929
- Country
- VRDN United States
- CET United States
- Employees
- VRDN N/A
- CET N/A
- Industry
- VRDN Medical Specialities
- CET Finance/Investors Services
- Sector
- VRDN Health Care
- CET Finance
- Exchange
- VRDN Nasdaq
- CET Nasdaq
- Market Cap
- VRDN 1.3B
- CET 1.4B
- IPO Year
- VRDN N/A
- CET N/A
- Fundamental
- Price
- VRDN $14.34
- CET $47.90
- Analyst Decision
- VRDN Strong Buy
- CET
- Analyst Count
- VRDN 11
- CET 0
- Target Price
- VRDN $38.50
- CET N/A
- AVG Volume (30 Days)
- VRDN 750.1K
- CET 20.5K
- Earning Date
- VRDN 08-07-2025
- CET 01-01-0001
- Dividend Yield
- VRDN N/A
- CET 4.79%
- EPS Growth
- VRDN N/A
- CET 26.33
- EPS
- VRDN N/A
- CET 9.95
- Revenue
- VRDN $302,000.00
- CET $23,698,535.00
- Revenue This Year
- VRDN N/A
- CET N/A
- Revenue Next Year
- VRDN $17,102.33
- CET N/A
- P/E Ratio
- VRDN N/A
- CET $4.73
- Revenue Growth
- VRDN 4.86
- CET 11.75
- 52 Week Low
- VRDN $9.90
- CET $40.24
- 52 Week High
- VRDN $27.20
- CET $49.51
- Technical
- Relative Strength Index (RSI)
- VRDN 50.32
- CET 58.42
- Support Level
- VRDN $14.11
- CET $46.75
- Resistance Level
- VRDN $16.05
- CET $47.78
- Average True Range (ATR)
- VRDN 0.74
- CET 0.54
- MACD
- VRDN -0.13
- CET -0.06
- Stochastic Oscillator
- VRDN 20.18
- CET 79.39
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
About CET Central Securities Corporation
Central Securities Corp is a non-diversified closed-end management investment company. Its investment objective is long-term growth of capital. The company invests in common stocks, bonds, convertible bonds, preferred stocks, convertible preferred stocks, warrants, options real estate, or short-term obligations of governments, banks, and corporations.